These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23597768)

  • 1. Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP).
    Rubin J; Venge P
    Mol Immunol; 2013 Oct; 55(3-4):372-80. PubMed ID: 23597768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein.
    Eriksson J; Woschnagg C; Fernvik E; Venge P
    J Leukoc Biol; 2007 Dec; 82(6):1491-500. PubMed ID: 17726151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications.
    Trulson A; Byström J; Engström A; Larsson R; Venge P
    Clin Exp Allergy; 2007 Feb; 37(2):208-18. PubMed ID: 17250693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil cationic protein (ECP) is processed during secretion.
    Woschnagg C; Rubin J; Venge P
    J Immunol; 2009 Sep; 183(6):3949-54. PubMed ID: 19692640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity.
    Rubin J; Zagai U; Blom K; Trulson A; Engström A; Venge P
    J Immunol; 2009 Jul; 183(1):445-51. PubMed ID: 19542456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines.
    Glimelius I; Rubin J; Fischer M; Molin D; Amini RM; Venge P; Enblad G
    Exp Hematol; 2011 Aug; 39(8):850-8. PubMed ID: 21679745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
    Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
    FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic Activities of Eosinophil Cationic Protein and Eosinophil-derived Neurotoxin: In Silico Analysis.
    De Oliveira PC; De Oliveira Lopes D; Do Vale Coelho IE; Pereira MC
    Cancer Genomics Proteomics; 2015; 12(6):397-402. PubMed ID: 26543086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
    Singh A; Batra JK
    Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein.
    Küster B; Hunter AP; Wheeler SF; Dwek RA; Harvey DJ
    Electrophoresis; 1998 Aug; 19(11):1950-9. PubMed ID: 9740055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes.
    Munthe-Kaas MC; Gerritsen J; Carlsen KH; Undlien D; Egeland T; Skinningsrud B; Tørres T; Carlsen KL
    Allergy; 2007 Apr; 62(4):429-36. PubMed ID: 17362255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.
    Belgacem O; Buchacher A; Pock K; Josic D; Sutton C; Rizzi A; Allmaier G
    J Mass Spectrom; 2002 Nov; 37(11):1118-30. PubMed ID: 12447888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
    Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
    Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
    Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP.
    Jönsson UB; Byström J; Stålenheim G; Venge P
    J Leukoc Biol; 2006 Apr; 79(4):846-51. PubMed ID: 16434694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
    Torrent M; Nogués MV; Boix E
    J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophil cationic protein: overview of biological and genetic features.
    de Oliveira PC; de Lima PO; Oliveira DT; Pereira MC
    DNA Cell Biol; 2012 Sep; 31(9):1442-6. PubMed ID: 22845733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study.
    Jönsson UB; Håkansson LD; Jõgi R; Janson C; Venge P
    BMC Pulm Med; 2010 Jun; 10():36. PubMed ID: 20534163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil cationic protein damages protoscoleces in vitro and is present in the hydatid cyst.
    Ramos AL; Discipio RG; Ferreira AM
    Parasite Immunol; 2006 Aug; 28(8):347-55. PubMed ID: 16879306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
    Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
    J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.